BioSyent Inc.
BIOYF
$8.50
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.95M | 1.46M | 1.62M | 1.15M | 1.69M |
| Total Depreciation and Amortization | 184.40K | 109.20K | 143.90K | 337.00K | 85.70K |
| Total Amortization of Deferred Charges | -37.60K | 44.50K | 3.20K | 700.00 | -- |
| Total Other Non-Cash Items | -38.10K | -19.50K | 15.70K | 212.80K | -58.80K |
| Change in Net Operating Assets | -45.80K | 915.90K | -2.28M | 335.90K | 3.12M |
| Cash from Operations | 2.01M | 2.51M | -500.60K | 1.87M | 4.84M |
| Capital Expenditure | 9.20K | -13.50K | -13.90K | -23.30K | -9.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 318.10K | 137.60K | 766.60K | 1.28M | -3.68M |
| Cash from Investing | 327.40K | 124.10K | 752.70K | 630.70K | -3.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -49.40K | -48.00K | -47.50K | -46.60K | -46.00K |
| Issuance of Common Stock | 34.40K | 6.30K | 58.50K | 162.20K | 50.20K |
| Repurchase of Common Stock | -16.80K | -23.50K | -955.60K | -3.79M | -22.80K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -408.80K | -406.70K | -392.50K | -366.40K | -382.30K |
| Other Financing Activities | -12.10K | -12.60K | -13.10K | -14.00K | -14.60K |
| Cash from Financing | -440.70K | -463.00K | -1.06M | -3.00M | -406.70K |
| Foreign Exchange rate Adjustments | 5.10K | -5.00K | -500.00 | 22.30K | -18.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.90M | 2.16M | -808.10K | -477.20K | 720.10K |